Phase Ii Study Of Pi3k Inhibitor Copanlisib In Cancer Patients With Deleterious Pten Mutations And Retained Pten Protein Expression: Results From The Nci-Match Trial (Eay131) Sub-Protocol Z1h

F. Janku, Z. Wei, M. A. Davies,E. P. Mitchell,J. J. Wright,L. A. Doyle,R. J. Gray,V. Wang,L. M. Mcshane, L. V. Rubinstein, D. R. Patton,P. M. Williams, S. R. Hamilton, B. Conley, C. L. Arteaga,L. N. Harris,P. J. O'Dwyer,A. P. Chen,K. T. Flaherty

ANNALS OF ONCOLOGY(2021)

引用 1|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要